|
RNF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.225850E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.055100E-03 |
| Normal-vs-Stage2 |
4.434200E-01 |
| Normal-vs-Stage3 |
9.577800E-01 |
| Normal-vs-Stage4 |
8.996200E-01 |
| Stage1-vs-Stage2 |
4.603600E-01 |
| Stage1-vs-Stage3 |
1.026970E-01 |
| Stage1-vs-Stage4 |
2.919600E-01 |
| Stage2-vs-Stage3 |
5.965600E-01 |
| Stage2-vs-Stage4 |
6.712400E-01 |
| Stage3-vs-Stage4 |
9.599600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.540000E-03 |
| Normal-vs-AfricanAmerican |
1.324040E-01 |
| Normal-vs-Asian |
9.336200E-01 |
| Caucasian-vs-AfricanAmerican |
6.692200E-01 |
| Caucasian-vs-Asian |
6.047200E-01 |
| AfricanAmerican-vs-Asian |
8.208800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.664800E-03 |
| Normal-vs-Female |
6.999600E-01 |
| Male-vs-Female |
5.721600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.315930E-02 |
| Normal-vs-Extreme_Weight |
2.389000E-04 |
| Normal-vs-Obese |
6.032200E-01 |
| Normal-vs-Extreme_Obese |
2.303400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.755800E-01 |
| Normal_Weight-vs-Obese |
1.116430E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.026600E-01 |
| Extreme_Weight-vs-Obese |
1.784070E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.073600E-01 |
| Obese-vs-Extreme_Obese |
4.872200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.948600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.240570E-01 |
| Normal-vs-Age(61-80Yrs) |
5.021100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.420410E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.378000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.257410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.126100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.498620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.123800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.282000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.061900E-03 |
| Normal-VS-Type2 PRCC |
1.985400E-01 |
| Normal-VS-KIRP CIMP |
6.988000E-01 |
| Normal-VS-Unclassified PRCC |
6.302000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.796400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.760000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.868430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.855400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.004600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.597200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.66510000000032E-05 |
| Normal-vs-N1 |
3.686400E-01 |
| Normal-vs-N2 |
4.886800E-01 |
| N0-vs-N1 |
3.112200E-02 |
| N0-vs-N2 |
3.565800E-01 |
| N1-vs-N2 |
5.718000E-01 |
|
|
